×
Volver a Agenda
LS34: Impact of COVID-19 on US Clinical Studies Conducted by Japan-Based Pharmaceutical Companies
Session Chair(s)
Kazumi Taguchi, MSc
Discovery Accelerator,EIR Business Lead
Astellas Pharma, Japan
Speaker(s)
Yu Tanaka
Project Planning & Management Forum NY Chapter, United States
Project Manager
Takahiro Yoshida
MSD, Japan
Clinical Research Specialist, Study Operation
¿Tiene una cuenta?